(AMLX) Amylyx Pharmaceuticals - Performance 238.4% in 12m
AMLX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-37.24%
#92 in Peer-Group
Rel. Strength
98.08%
#144 in Stock-Universe
Total Return 12m
238.38%
#7 in Peer-Group
Total Return 5y
-65.36%
#113 in Peer-Group
P/E | Value |
---|---|
P/E Trailing | - |
P/E Forward | 2.77 |
High / Low | USD |
---|---|
52 Week High | 7.03 USD |
52 Week Low | 1.65 USD |
Sentiment | Value |
---|---|
VRO Trend Strength +-100 | 87.31 |
Buy/Sell Signal +-5 | 0.00 |
Support / Resistance | Levels |
---|---|
Support | |
Resistance |
12m Total Return: AMLX (238.4%) vs XLV (-7.1%)

5y Drawdown (Underwater) Chart

Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-3.67% | 143% | 342% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
LLY NYSE Eli Lilly |
9.25% | -11.8% | 416% | 63.7 | 36 | 1.2 | 58.2% | 18.9% |
NVS NYSE Novartis |
4.23% | 13.9% | 74.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
NOVN SW Novartis |
1.41% | 2.61% | 46.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
GSK NYSE GlaxoSmithKline |
-2.94% | -0.85% | 47.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
SFZN SW Siegfried Holding |
-7.61% | -1.2% | 117% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
AZN NASDAQ AstraZeneca |
-1.8% | -10.9% | 47.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
IPN PA Ipsen |
1.16% | -10.2% | 43.5% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: AMLX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AMLX
Total Return (including Dividends) | AMLX | XLV | S&P 500 |
---|---|---|---|
1 Month | 32.63% | 1.80% | 3.01% |
3 Months | 65.61% | -7.39% | 5.82% |
12 Months | 238.38% | -7.13% | 12.82% |
5 Years | -65.36% | 47.29% | 114.16% |
Trend Score (consistency of price movement) | AMLX | XLV | S&P 500 |
---|---|---|---|
1 Month | 58% | 54% | 78.3% |
3 Months | 78% | -57.4% | 87.1% |
12 Months | 65.4% | -69.2% | 43.5% |
5 Years | -70.2% | 88.1% | 84% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
---|---|---|---|
1 Month | #15 | 30.28% | 28.76% |
3 Month | #14 | 78.82% | 56.51% |
12 Month | #8 | 264.35% | 199.92% |
5 Years | #104 | -67.14% | -74.70% |
FAQs
Does Amylyx Pharmaceuticals (AMLX) outperform the market?
Yes,
over the last 12 months AMLX made 238.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%.
Over the last 3 months AMLX made 65.61%, while XLV made -7.39%.
Performance Comparison AMLX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AMLX vs. Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 20.8% | 29.6% | 52.2% | 226% |
US NASDAQ 100 | QQQ | 20.3% | 28.7% | 51.4% | 225% |
German DAX 40 | DAX | 22% | 35.7% | 36.6% | 210% |
Shanghai Shenzhen CSI 300 | CSI 300 | 19.2% | 28.4% | 51.7% | 219% |
Hongkong Hang Seng | HSI | 18.4% | 24.4% | 33.2% | 203% |
India NIFTY 50 | INDA | 20.5% | 31.8% | 50.5% | 238% |
Brasil Bovespa | EWZ | 24.6% | 32.3% | 30.2% | 232% |
AMLX vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 20.8% | 29.1% | 47% | 215% |
Consumer Discretionary | XLY | 21.3% | 34.2% | 62.2% | 219% |
Consumer Staples | XLP | 22.3% | 34.5% | 51.9% | 232% |
Energy | XLE | 26% | 29.6% | 52.3% | 243% |
Financial | XLF | 20% | 31.3% | 48.4% | 212% |
Health Care | XLV | 21.8% | 30.8% | 57.1% | 246% |
Industrial | XLI | 21.3% | 32% | 46.1% | 219% |
Materials | XLB | 22.5% | 32.6% | 51.1% | 239% |
Real Estate | XLRE | 23.3% | 31.9% | 51.4% | 226% |
Technology | XLK | 19.4% | 25.1% | 49.9% | 228% |
Utilities | XLU | 22.1% | 33.4% | 46.8% | 218% |
Aerospace & Defense | XAR | 20.1% | 27.9% | 35.4% | 194% |
Biotech | XBI | 22% | 27.6% | 63.9% | 249% |
Homebuilder | XHB | 18.8% | 32.4% | 62.2% | 242% |
Retail | XRT | 22.3% | 32.3% | 59.9% | 236% |
AMLX vs. Commodities
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Oil | USO | 33.6% | 23.7% | 53.6% | 245% |
Natural Gas | UNG | 35.1% | 39.8% | 50.7% | 255% |
Gold | GLD | 23.8% | 31.8% | 27.5% | 195% |
Silver | SLV | 23.5% | 23.4% | 32.2% | 213% |
Copper | CPER | 21.1% | 28.6% | 34.6% | 225% |
AMLX vs. Bonds
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
iShares 20+ Years Bond | TLT | 21.8% | 30.2% | 52.4% | 242% |
iShares High Yield Corp. Bond | HYG | 22% | 31.3% | 49.7% | 229% |